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The purpose of this review is to highlight the healthcare inequities faced by pediatric and 
adolescent young adult (AYA) oncology patients; highlighting disparities in treatment faced by 
racial/ethnic minorities, individual identifying as part of the LGBT+ (Lesbian, Gay, Bisexual, 
Trans, Queer and other sexualities and/or identities) population and those with differing abilities. 
We review known barriers and disparities that exist for these select groups and provide an 
overview of potential evidence-based changes that could be implemented to address some of 
these inequities.  
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ADA  Americans with Disabilities Act of 1990 
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AML  Acute Myeloid Leukemia 
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NCI  National Cancer Institute 
 
PHO Pediatric Hematology & Oncology Division within the University of North Carolina 
School of Medicine 
 
SOC Standard of Care 
 
UNC-H Single entity of UNC HealthCare – including NC Children’s Hospital &  
Lineberger Comprehensive Cancer Center 
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PEDIATRIC AND AYA ONCOLOGY  
Background 
Pediatric oncology encompasses all solid and hematologic malignancies in patients 
between the ages of 0-21 (Cancer.gov, 2020). The two most common hematologic cancer 
diagnoses are leukemia (ALL) & lymphoma (Lly) while the most common solid cancer 
diagnoses are brain & central nervous system cancers (CNS). A new subspecialty that has 
emerged in the past ten years focuses on Adolescents and Young Adults (AYA) patients that 
have been diagnosed with any cancer between the ages of 13-39 (Lewis et al., 2014). Both 
pediatric and AYA oncology have unique trainings or fellowships that providers must complete; 
the care provided by both specialties cross over frequently and results in a collaborative 
relationship to ensure that any patient diagnosed between the ages of 0-39 have the best care 
and outcomes possible. Additionally, as pediatric oncology survival rates have continued to rise, 
patients live longer but now, must also deal with the long-term side effects of pediatric oncology 
therapy throughout their adulthood (O’Leary et al., 2008).  
In the United States (US), there are greater than 10,000 new pediatric cancer diagnoses 
yearly; greater than 70,000 diagnoses for patients within the AYA range of 15-29 are diagnosed 
yearly (National Cancer Institute [NCI] Childhood Cancer, 2020; NCI AYA, 2020).  Between 10-
20% of these patients will die due to their malignancy - making cancer the leading cause of 
death for children and the fourth leading cause of death for AYA patients (NCI Childhood 
Cancer, 2020; NCI AYA, 2020).  
Long-term Effects of Pediatric or AYA Cancer Diagnosis 
The implications of a pediatric or AYA cancer diagnosis exceeds just the physical effects 
that patients will experience during treatment; patients, caregivers and families can experience 
extensive financial, emotional, physical burdens (Dockerty et at., 2003; Vannatta & Gerhardt, 




As reported by Pelletier & Bona (2015), financial hardships affect a majority of the 
pediatric oncology population and affect families from all socio-economic groups (Pelletier & 
Bona, 2015). In fact, more than 1/3 of families will lose between 40-50% of their yearly income 
due to the cost associated with a family member’s pediatric oncology diagnosis (Bona, 2014). 
While financial burdens may affect a majority of families, those in lower-income brackets are 
affected more significantly as the cost associated with treatment require a greater proportion of 
their income than their wealthier counterparts (Bona et al., 2014).  
Understandably, caregivers suffer from emotional distress throughout patient treatment 
(Edmond et al, 2016). As many as 5-10% of caregivers and/or parents will develop 
posttraumatic stress disorder, while more than half will experience distress levels consistent 
with PTSD (National Children’s Cancer Society [NCCS], 2018). Disparities in caregiver & patient 
distress have been reported, with racial & ethnic minorities and those with lower socioeconomic 
status reporting higher levels of distress (Nam et al, 2016)  
Pediatric and AYA oncology patients can suffer from long-term side effects from 
treatment. These side effects can include physical side effects – such as reproductive or sexual 
dysfunction, cardia disease, neurocognitive deficits - as well as behavioral, psychosocial, 
financial, or other types of issues (Baker & Syrjala, 2018; Jacobs & Pucci, 2013)). More than 
60% of pediatric and AYA patients will be diagnosed with a severe long-term side effect that will 
continue to place additional burdens of the patient (Kopp et al, 2012). 
Disparities & Barriers to Care 
The disparities that exist among the quality, type and breadth of healthcare provided to 
patients – with or without a cancer diagnosis – have been studied over the past three decades  
Certain marginalized groups have been found to receive poorer care as compared to their 
counterparts (Balsa et al., 2003; Penner et al, 2012).  
Racial and ethnic minorities have been found to receive poorer care, have worse 




US (Palanker, 2008 ). The Children’s Oncology Group (COG) – the pediatric oncology 
cooperative group funded by the NCI to conduct pediatric and AYA oncology therapeutic and 
translational research studies – has reported similar trends among pediatric cancer patients, 
with racial and ethnic minorities experiencing worse outcomes and high rates of mortality. 
(Armenian et al, 2012; Morris et al, 2010).  
Those from the LGBTQ+ population have also been found to have worse health 
outcomes than their hetero/cis-gender counterparts (Fredrisksen-Goldsen et al., 2012). 
Research has also confirmed that those from the LGBTQ+ population that have a cancer 
diagnosis suffer worse outcomes and are not provided the same care offered to other patients 
(Fish et al., 2018).  
Patients with DAs are those that have any restriction or diminishing ability to complete 
the tasks of everyday life like showering, eating or doing chores (NCI, 2020). Between 10-20% 
of the US population has DAs; the US has passed laws to address discrimination faced by those 
from the DAs (Shakespeare et al, 2009). This law outlines the protection in place for those with 
DAs as well as the federal guidelines for healthcare office space that can address the barriers 
that those with DAs typically face in the healthcare setting (ADA, 2009). Although this law was 
passed in 1991 and has been amended since there exist minimal changes in layouts of 
healthcare clinics and many of the barriers identified in 1991 still persist (Sherman & Sherman, 
2011) 
Pediatric and AYA cancers are considered rare – by NCI definition, rare cancers occur in 
less than 15/100,000 people per year (NCI, 2020). The limited number of patients has led to a 
lack of data about the general pediatric and AYA oncology population (Cahill & Makadon, 2013; 
Munoz-Blacno et al., 2017; Ortega el al, 2007; Clarke, 2019). It is fair to assume that if minimal 
data has been collected regarding pediatric and AYA oncology patients, there are even less 




Role of the UNC Healthcare System 
The UNC Healthcare (UNC-H) system is a state-funded single entity that provides 
healthcare to the state of NC; the NC Children’s Hospital (NCCH) & Lineberger Comprehensive 
Cancer Center (LCCC) are both parts of the UNC-H system. NCCH is the only state-funded 
children’s hospital in NC and provides treatment to any patient, regardless of barriers that may 
affect a patient’s ability to receive care at other institutions (i.e. lack of insurance or ability to pay 
for service, immigration status, and lack of access to medical centers in rural areas). Per report 
(Gold, 2020), UNC treats pediatric and AYA patients that are from the marginalized groups 
mentioned previously – as well as patients that are undocumented, uninsured or any 
combination of the groups listed.  
The UNC-H system is paid by and created to treat the citizens of NC; the UNC-H 
mission is, “to improve the health and wellbeing of North Carolinians and others whom [UNC-H] 
serve[s]” (UNC Health, 2020). To provide the people of NC with the best quality of care, it must 
a priority for UNC-H to address any disparities that exist. The author acknowledges that the 
changes that would be required to address every disparity that exists for any marginalized group 
would undoubtedly involve systematic changes that would take years – perhaps even decades 
– to implement. Nonetheless, there are ways that UNC could address some of these disparities 
to lessen the burden for the pediatric and AYA oncology populations treated at UNC.  
As a first step, the author will provide a review of the disparities that impact the care 
provided to pediatric and AYA oncology patients from those groups identified previously - racial 
& ethnic minorities and those from the LGBTQ+ community. As patients with DAs face physical 
barriers, this population will also be included. For this review, our specific focus will be on the 




DISPARITIES AMONG MARGINALIZED GROUPS 
Disparities Encounted by Racial & Ethnic Minority Patients 
Racial and ethnic minorities – including those that have immigrated to the US without 
proper documentation – face systemic barriers when seeking healthcare. As the population of 
the US continues to increase, the number of patients that will be affected by those disparities 
will also increase (US Census, 2020). There exist disparities in both the health of individuals 
and the healthcare access available to children from racial and ethnic minorities; these 
disparities are seen worldwide (Calza et al., 2016; Hacker et al., 2015; Goodburn, 2014; Flore, 
2012; Gee & Ford, 2011; Chu et al., 2007) 
In the US, pediatric patients from racial minorities are not provided the same information, 
do not receive the same quality of care and have worse outcomes than their Caucasian non-
minority counterparts (Bhatia, 2011; Illowite et al., 2017). For caregivers from minority groups 
that speak non-English languages, language barriers harm the ability of caregivers to make an 
informed decision regarding treatment and correspondingly, those language barriers negatively 
impact the healthcare experience from the perspective of the caregiver (Zamaora et al., 2016).  
Racial minorities are underrepresented in pediatric oncology research (Duma et al., 
2017; Hamel et al., 2016); research shows that for these group many miscommunication issues 
exist before and during the informed consent process that may affect the willingness of patient 
participation in clinical trials (Simon & Kodish, 2005; Rick & Schabath, 2018). This is extremely 
problematic considering that within the pediatric oncology community, clinical trial enrollment is 
considered the standard of care (SOC) as treatment evolves quickly (Unguru, 2011).  Within the 
US, Hispanic and African American patients do not participate in research as much as their non-
minority counterparts that adds yet another barrier to quality healthcare on top of the other 
barriers these patient encounters (Aristizabal et al., 2015; Ford et al., 2007). Without the 




widen and continues to hinder obtaining new information about those groups that could be used 
when attempting to address the disparities.  
Undocumented patients face additional barriers to accessing quality healthcare, 
including fear of deportation, federal governmental action, or discrimination; lack of financial 
resources or stigma (Hacker et al, 2015). Undocumented patients both utilize healthcare 
services less than other groups and report worse experience in healthcare settings (Ortega et 
al, 2007). Providers for undocumented patients may also experience ethical dilemmas, which 
affects the type of care and treatment provided to those patients (Jepson et al., 2010). Providers 
may feel conflicted in wanting to provide oncology care for undocumented patients but there 
likely exist federal or state guidelines that may prohibit providing services to those without 
insurance or there may be a restriction (based on immigration status) for subsidized-care. Many 
healthcare organizations attempt to implement programs to address some of these disparities, 
but there are limited programs for undocumented patients and access to those programs is 
minimal (Nunnery et al., 2016).  
Disparities Encounted by LGBTQ+ Patients 
 There also exist disparities in both the health, the healthcare provided to pediatric, and 
AYA patients that identify as part of the LGBTQ+ community (Institute of Medicine [IOM], 2011; 
Silberholz et al. 2017; Gibson et al., 2017. For instance, due to lack of disclosure of or LGBTQ+ 
status – from patient-to-provider or provider-to-patient -, patients that identify as LGBTQ+ are 
not provided adequate health information. Specifically, this population is often not provided 
information regarding risks that are known to increase for those that identify as LBGTQ+ (Quinn 
et al., 2014). Without the appropriate information, patients are not able to make educated 
decisions related to their healthcare –  despite evidence that increased patient education 
improves outcomes (Boyle & Bubalo, 2007; Stromberb, 2005). When this population does 
receive care, it is often not an equivalent quality of care as provided to their non-LGBTQ+ 




providers are rarely provided the training to fully understand the specific need of the LGBTQ+ 
population which unfortunately can result in disparities in care. Again, the lack of equal 
treatment for patients from this marginalized group will lead to worse outcomes and a greater 
burden for patients and caregivers.  
Disparities Encounted by Patients with Differing Abilities (DAs) 
Individuals with DAs have a similar incidence of a cancer diagnosis as those without 
DAs (Sullivan et al., 2004; Patja et al., 2001). There are subgroups of individuals with DAs, such 
as children diagnosed with Trisomy 21 (previously referred to as “Downs Syndrome”), who have 
a significantly higher chance of being diagnosed with acute lymphocytic leukemia (ALL) or acute 
myeloid leukemia (AML) than children without Trisomy 21– up to a 20-fold increased risk (Rabin 
& Whitlock, 2009; Hill et al., 2003)! 
This population can encounter extensive barriers that are not as common with other 
marginalized groups – such as lack of disability awareness by providers, discontinuity of care or 
expectations of what is considered “normal” by healthcare providers (Acharya et al, 2017). Not 
only do these barriers affect the way these patients can navigate the healthcare system and 
receive appropriate treatment but they even affect the way these patients can physically 
navigate clinical spaces (Sakellarious et al, 2018). For instance, those in wheelchairs have been 
found to receive inconsistent physical evaluations and fewer screenings than their able-bodied 
counterparts; not surprisingly, these patients also believe they receive poorer care than other 
patients - which in fact appears to be true (Stillman et al., 2017). Again, the lack of equal 
treatment for patients from this marginalized group will lead to worse outcomes and a greater 
burden for patients and caregivers. 
Implication of Disparities 
Patients are multifaceted - and could be part of none, some, all or other marginalized 
groups than those described above. As mentioned, there is minimal research conducted on 




many patients, additional research is needed to be able to assess the niche barriers and 
disparities faced by those select patients (Magana et al., 2013). Many of the individuals in the 
groups listed above not only encounter the disparities listed but also face microaggressions 
(brief and commonplace daily verbal, behavioral or environmental indignities) - when interacting 
with providers and the healthcare system (Eliason & Dibble, 2015).  
In the end – pediatric and AYA patients are not being provided the same care. Due to 
the disparities in care, there are specific groups that have worse outcomes, greater 
financial/social/emotional burden and are affected in a greater way than other patients. No 
pediatric or AYA patient could ever control or make any decision regarding their race, ethnicity, 
sexual orientation/identity or able-bodiedness – so why are those patients being provided worse 







UNC PEDIATRIC & AYA POPULATION 
UNC Demographics 
Per a report from the PHO Division Chief (Gold, 2020), the PHO Oncology practice sees 
between 80-110 new pediatric & AYA cases per year; this number includes patients both newly 
diagnosed and those that have either relapsed or progressed. This number also includes those 
patients enrolled in clinical trials supported by PHO as many of the PHO research studies allow 
enrollment of patients greater than 18 years old – some studies even have no upper age limit 
and will allow enrollment of any pediatric, AYA or adult patients via a pediatric protocol.  
Dr. Gold confirmed that between 30-50% of new patients each year self-report as 
minorities (African American, American Indian/Alaska Native, Asian or Pacific Islander); 
additionally, between 20-40% of new patients each year self-identify as Hispanic. Although no 
data has been collected in regards to the number of LGTBQ+ pediatric or AYA patients, it would 
be reasonable to assume there is at least one patient treated in the PHO practice per year that 
would fall in that group. Similarly, patients with DAs may have information about any DAs 
documented in their medical records, but the discrete number of patients with DAs that are 
treated by PHO is not documented. Again, it can be assumed that at least one patient treated in 
the PHO practice per year would fall into this group.  
 As the state-funded hospital created and maintained to provide the best care to all North 
Carolinians, UNC-H has a responsibility to address disparities for any pediatric or AYA patients 
discussed previously. Even if disparities only exist for a limited number of patients – even if only 
a single patient – those are still barriers that must be addressed for those patients to receive the 
best care possible.  
Changes in the UNC-H Pediatric and AYA Oncology Practices 
Over the past 20 years, the PHO division has grown tremendously. Since 2000, both the 
number of providers treating patients and the clinical research staff have tripled. The number of 




studies available for enrollment at a time. The type of treatment available and able to be 
delivered within UNC-H has also dramatically increased over the past 20 years. UNC-H can 
treat pediatric and AYA patients with many advanced therapeutic options that are not available 
at many other facilities such as MIBG treatment, CAR-T Cell Therapy, and stem cell transplant.  
Another development in the care available to patients has been the creation of the AYA 
Program that provides care and support to patients treated at UNC-H between 13-39 years 
(LCCC, 2020). The creation of the program was funded by the Be Loud! Sophie Foundation (Be 
Loud!, 2019). The Be Loud! Sophie Foundation was created by the family of a former UNC-H 
AYA patient, Sophie, who wanted to find a way to address the specific needs of adolescents 
and young adults. With the creation of the AYA program, the PHO practice has been able to 
recruit providers that have completed both pediatric and AYA training in hopes to be able to 







With such a large number of systemic sources of disparities and the ever-growing and 
changing population in the US, policy changes to either legislation or insurance will be 
necessary for many of these disparities to be addressed (Williams & Jackson, 2005; Hacker et 
al., 2015). US policy changes  take decades – but in the meantime, organizations can begin to 
implement low-risk, high-reward interventions at the local level that can begin to affect the 
barriers for those marginalized groups (Krahn et al., 2006), 
What is clear is that resources are needed in various modalities – from non-verbal 
communication (such as the use of sign-language or “charades”), interpreters, educational 
material for all involved with care, or trainings (Silberholz et al., 2017; Saeed, 2018; Pergert et 
al., 2008; Gibson, F, 2008). Training must be provided for all those associated with the 
treatment of patients – not just medical clinicians but all other types of providers that care for 
patients such as social worker, recreation life specialist, occupation/physical therapist, as well 
as clinic administrators (Davis, 2008 Glenn-Vega, 2002;). For many marginalized groups, 
clinical providers acknowledge their own lack of training and are eager to receive further 
education regarding these communities (Schabath et al., 2019, TJC, 2015; Griggs et al., 2017). 
In the future, this review will be used as the foundation for a diversity and inclusion 
initiative that will begin the process to start addressing the disparities that are specific to patient 
seen within UNC-H. To be able to address the disparities encountered by patients specifically in 
the UNC-H system, data from those in the marginalized groups must be collected. Measures 
such as the Generic Short Patient Experiences Questionnaire could be used to collect 
information from these groups to assess how patients perceive their care and the disparities 
and/or barriers faced (Sjetne et al., 2011). This process could be completed during clinic visits in 
the inpatient or outpatient setting with collaboration from social workers or childlife specialist in 
the clinic that maintain a long-term relationship with families and patients throughout the entirety 




Once there is a greater understanding of the specific patient population of pediatric and 
AYA oncology patients at UNC-H, quality improvement initiatives could be created with the input 
from the various stakeholders involved. Using quality improvement guides such as those 
created by the Institute of Healthcare Improvement or Johns Hopkins to guide the quality 
improvement process would be a good use of resources already created (IHI, 2020; Johns 
Hopkins). A quality improvement plan would be created to provide guidance to UNC-H on how 
any evidence-based changes could be fully implemented to provide a more inclusive and 
equitable practice for all patients.  
The most reasonable approach would be to start with low-cost, low-risk initiatives that 
can quickly affect patient care. For instance, clinical interpreters improve patient care and 
provide a way for clinicians and patients to ensure effective communication (Jugner et al., 
2018); although there may be budgetary restrictions for hiring interpreters, there are many free 
software apps that can provide real-time translations and should be available for use with 
patients. Along with interpreters, clinic space should contain bilingual signage and translations 
of all patient-facing documents. Another low-cost, low-risk initiative would be to provide training 
to providers and clinical staff that address some of these disparities such as cultural 
competency training which is effective in improving the care provided to culturally diverse 
patient populations (Dabney et al., 2016). Utilizing the resources and tools of research that have 
been completed to address health care inequities and tailoring those resources and tools for the 
pediatric and AYA oncology population may a quick (and low-cost) way to address these 
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